China Northwest Factory Manufacturer MONOBENZONE / 4-Benzyloxyphenol CAS 103-16-2 For stock delivery

Brand Name:Leader
Certification:ISO,GMP,SGS,HALA,KOSER,HACCP
Model Number:LD
Minimum Order Quantity:25KGS
Delivery Time:2-3 working days
Payment Terms:Western Union, MoneyGram, T/T, L/C
Contact Now

Add to Cart

Site Member
Supplier`s last login times: within 1 hours
Product Details Company Profile
Product Details
PBP Chemical Properties
Melting point119-120 °C(lit.)
Boiling point297.96°C (rough estimate)
density1,26 g/cm3
refractive index1.5906 (estimate)
storage temp.-20°C
pka10.29±0.15(Predicted)
formPowder, Crystals, and/or Chunks
colorOff-white to beige to brown
Water Solubilityslightly soluble
Merck14,6248
BRN1958305
InChIKeyVYQNWZOUAUKGHI-UHFFFAOYSA-N
CAS DataBase Reference103-16-2(CAS DataBase Reference)
NIST Chemistry ReferenceMonobenzone(103-16-2)
EPA Substance Registry SystemMonobenzone (103-16-2)
Safety Information
Hazard CodesXi
Risk Statements36-43
Safety Statements24/25-26-37
WGK Germany2
RTECSSJ7700000
Hazard NoteIrritant
TSCAYes
HS Code29095090
Hazardous Substances Data103-16-2(Hazardous Substances Data)
ToxicityLD50 i.p. in mice: >600 mg/kg (Takahashi)
MSDS Information
ProviderLanguage
PBPEnglish
SigmaAldrichEnglish
ACROSEnglish
ALFAEnglish
PBP Usage And Synthesis
AbstractMonobenzone, also called 4-(Benzyloxy)phenol and monobenzyl r of hydroquinone (MBEH) is an organic chemical in the phenol family with chemical formula C6H5CH2OC6H4OH. It is used as a topical drug for medical depigmentation. Monobenzone occurs as a white, almost tasteless crystalline powder, soluble in alcohol and practically insoluble in water.
The topical application of monobenzone in animals, increases the excretion of melanin from the melanocytes. The same action is thought to be responsible for the depigmenting effect of the drug in humans.
Treatment for vitiligoMonobenzone may cause destruction of melanocytes and permanent depigmentation.Hyperpigmented skin appears to fade more rapidly than does normal skin, and exposure to sunlight reduces the depigmenting effect of the drug. The histology of the skin after depigmentation with topical monobenzone is the same as that seen in vitiligo; the epidermis is normal except for the absence of identifiable melanocytes.This function enables it treat the uneven appearance of the skin due to a loss of skin color (vitiligo). It works by permanently removing color from normal skin located around skin with vitiligo. This will help to make the appearance of the skin more even.
What calls for special attention is that: Do not use this drug to treat other skin discoloration problems ("sun spots," "age spots," freckles, skin discoloration caused by hormone medicine, perfumes, pregnancy, or skin trauma). Monobenzone is not a mild cosmetic bleach. Because it causes a permanent discoloration of the skin, it may not be the right treatment for these other skin conditions.
Besides, Monobenzone is also being considered for the treatment of Melanoma.
How to useThis medication is for use on the skin only. Apply a thin layer of the medication to normal-colored skin, usually 2-3 times daily or as directed by your doctor. Avoid getting this product in your eyes or on the inside of your nose or mouth. If you do get this medication in those areas, flush with plenty of water.After using this medication, the skin will be permanently affected and sensitive to sunlight. Avoid prolonged exposure to sunlight, tanning booths, and sunlamps. Always use a sunscreen of SPF 15 or greater, and wear protective clothing when outdoors.It may take up to 4 months before the full benefit of this drug takes effect. Once the desired skin color is achieved, this medication is applied only as needed to maintain your new skin color (usually 2 times a week).Use this medication regularly to get the most benefit from it. To help you remember, use it at the same times each day.Inform your doctor if your condition persists or worsens after 4 months.
You should not use this medication if you are allergic to monobenzone. Do not use monobenzone on any areas that are not affected by vitiligo.
CategoryToxic substance
Toxic gradingModerate toxicity
Acute toxicityAbdomen-rat LD50: 4500 mg/kg
Stimulate dataSkin-guinea pigs 5%/48 hours, mild grade.
Flammability hazard characteristicsThe drug is combustible, and combustion releases stimulus smoke.
StorageVentilated warehouse, low temperature, dry; Separated from food raw materials.
Extinguishing agentDry powder, foam, sand, carbon dioxide, mist water.
Referenceshttp://www.medicinenet.com/monobenzone-topical/article.htm
https://www.drugs.com/pro/benoquin.html
http://www.emedicinehealth.com/drug-monobenzone_topical/article_em.htm#important
DescriptionMay cause depigmentation
Chemical Propertiescream to beige-light brownish crystals or
UsesPBP is used as antiinflammatory, antisecretory, antiulcer.
UsesHydroquinone monobenzyl r is an antidegradant added to rubber products; inhibitor in acrylic resins.
IndicationsMonobenzone (Benoquin) potently inhibits melanin production and destroys melanocytes. Like hydroquinone, monobenzone was originally introduced for the topical treatment of disorders of excess melanin pigmentation, including melasma. It is now used only to permanently depigment the remaining normally pigmented skin in patients with extensive vitiligo. Irritant and allergic contact dermatitis are common side effects.
DefinitionChEBI: The monobenzyl r of hydroquinone. It is used as a topical drug for medical depigmentation.
Brand nameBenoquin (Valeant).
Synthesis Reference(s)Tetrahedron Letters, 33, p. 5129, 1992 DOI: 10.1016/S0040-4039(00)61209-1
Purification MethodsCrystallise it from EtOH or H2O, and dry (P2O5) under vacuum. [Walter et al. J Am Chem Soc 108 5210 1986, Beilstein 6 IV 5778.]
PBP Preparation Products And Raw materials
China China Northwest Factory Manufacturer MONOBENZONE / 4-Benzyloxyphenol CAS 103-16-2 For stock delivery supplier

China Northwest Factory Manufacturer MONOBENZONE / 4-Benzyloxyphenol CAS 103-16-2 For stock delivery

Inquiry Cart 0